Clinical Trial Update: Phase II Study Of Roferon and Accutane For Patients With T-Cell Malignancies [Phase 2]

View source ↗

Summary

Phase II study evaluating Roferon and Accutane in patients with T-cell malignancies completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hematologic Neoplasms
• Mycosis Fungoides
• T-cell Lymphoma

Drugs mentioned

• Accutane (isotretinoin)
• Roferon (Interferon alfa-2a)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma, T-Cell, Mycosis Fungoides | Phase 2 | Status: COMPLETED